N-Methyl-3-(1-(4-(Piperazin-1-Yl)Phenyl)-3-(4'-(Trifluoromethyl)-[1,1'-Biphenyl]-4-Yl)-1H-Pyrazol-5-Yl)Propanamide N-甲基-3-(1-(4-(哌嗪-1-基)苯基)-3-(4'-(三氟甲基)-[1,1'-联苯基]-4-基)-1H-吡唑-5-基)丙胺

CAS 2070015-22-2 MFCD170015222

化学结构图

2070015-22-2
SMILES:

别名和识别编码

Chemical NameN-Methyl-3-(1-(4-(Piperazin-1-Yl)Phenyl)-3-(4'-(Trifluoromethyl)-[1,1'-Biphenyl]-4-Yl)-1H-Pyrazol-5-Yl)Propanamide
Chemical Name TranslationN-甲基-3-(1-(4-(哌嗪-1-基)苯基)-3-(4'-(三氟甲基)-[1,1'-联苯基]-4-基)-1H-吡唑-5-基)丙胺
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Liu TM, et al. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells. Blood. 2015 Jan 8;125(2):284-95.
  • [1]. Su-Lin Lee,et al Identification and Characterization of a Novel Integrin-Linked Kinase Inhibitor.J Med Chem. 2011 Sep 22; 54(18): 6364–6374
  • [1]. Su-Lin Lee,et al Identification and Characterization of a Novel Integrin-Linked Kinase Inhibitor.J Med Chem. 2011 Sep 22; 54(18): 6364–6374
  • [2]. Liu TM, et al. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells. Blood. 2015 Jan 8;125(2):284-95.

系列性分类

  1. Medical Research Areas
  2. Cytosketetal Signaling
  3. Integrin  (整合素)

相关产品推荐